Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Healthcare Analyst

Dr Philippa Gardner

Dr Philippa Gardner
Healthcare Analyst

Lala Gregorek

Lala Gregorek
Director of Healthcare Research and Strategy

Pooya Hemami

Pooya Hemami
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Analyst

Maxim Jacobs

Maxim Jacobs
Director of Healthcare Research, North America

Dr Susie Jana

Dr Susie Jana
Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Analyst

Dr Linda Pomeroy

Dr Linda Pomeroy
Analyst

Dr John Savin

Dr John Savin
Analyst

Juan Pedro Serrate

Juan Pedro Serrate
Associate Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Analyst

By region

Recent initiations

Collplant Holdings Nuevolution
Xbrane Biopharma LifeWatch
Acarix Biondvax Pharmaceuticals

Recent QuickViews

Novacyt

Innovative clinical diagnostics

Pharmaceutical & healthcare | published 21/03/2017
Smith & Nephew

All parts now in place to move forward

Pharmaceutical & healthcare | published 14/02/2017
Nuevolution

Delivering on promises

Pharmaceutical & healthcare | published 04/01/2017
Nuevolution

Amgen deal: A significant step forward

Pharmaceutical & healthcare | published 23/11/2016

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

Prima BioMed

Initial LAG-3 combo data presented

ADR Update | Pharmaceutical & healthcare | 23/03/2017

Prima BioMed has presented encouraging early signs of efficacy from the TACTI-mel trial of IMP321 in combination with Keytruda, with one of the six melanoma…

ReNeuron Group

Clinical pipeline progressing as planned

Outlook | Pharmaceutical & healthcare | 23/03/2017

ReNeuron reported in December 2016 positive Phase II trial data for its CTX cells in chronic stroke patients, despite not meeting the three-month time…

Prima BioMed

Initial LAG-3 combo data presented

Update | Pharmaceutical & healthcare | 22/03/2017

Prima BioMed has presented encouraging early signs of efficacy from the TACTI-mel trial of IMP321 in combination with Keytruda, with one of the six melanoma…

Newron Pharmaceuticals

Xadago receives FDA approval in PD

Flash note | Pharmaceutical & healthcare | 22/03/2017

Newron and its partners Zambon and US WorldMeds have announced that the FDA has approved Xadago (safinamide) for Parkinson’s disease (PD) patients…

Selvita

SEL24 enters Phase I/II

Outlook | Pharmaceutical & healthcare | 20/03/2017

Selvita delivered on both fronts in 2016. We expect sales to have grown a solid 21% y-o-y, with an R&D milestone met and the FDA accepting an investigational…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies